Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prasugrel versus clopidogrel in patients with high platelet reactivity after elective PCI with drug-eluting stent
2008-004997-41Phase 2Terminated
- Sponsor
- Eli Lilly and Company
- Start
- Oct 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in coronary arteriosclerosis comparing Prasugrel plus aspirin with Clopidogrel plus aspirin (2 arms). Started Oct 2008; status: terminated.
02
Drugs
prasugrelclopidogrelaspirin
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on 2008-004997-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004997-41.